OC Replay

Join Dr. Angela Cheung as she will discusses what XLH is, the cause and symptoms, how to test for and diagnose the disease, prognosis and how to support patients.

Join Dr. Angela Cheung as she speaks to how the denosumab biosimilar compares to the reference drug, what physicians can expect from the clinical results, information on treatment plans, what healthcare providers need to communicate with their patients and more.

Join Dr. Alan Low as he shares information on Biologics & Biosimilars – An Overview for Healthcare Providers. Information presented will include how biologics and biosimilars work, the benefits of biosimilars and how to speak to patients about these new treatment options.

Join Dr. Suzanne Morin, lead author and Chair of the 2023 guideline steering committee, as she discusses an overview of the guideline which contain 25 recommendations and 10 good practice statements with a focus on exercise, nutrition, fracture risk assessment, treatment and more – reflecting advances in risk assessment, and non-pharmacologic and pharmacologic management of osteoporosis.

Join Dr. Rowena Ridout as she presents an introduction to the new guideline with information on the main areas of focus: exercise, nutrition, fracture risk assessment, treatment and more.

There is a resurgence of myths around calcium and how to best obtain this bone building nutrient for the benefit of bone health. This webinar intended for healthcare providers had an expert panel discuss and dispel the most common myths in their field of expertise.